BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
17.27
+0.14 (0.82%)
At close: Dec 5, 2025, 4:00 PM EST
17.50
+0.23 (1.33%)
After-hours: Dec 5, 2025, 6:36 PM EST
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $333.92 million as of December 5, 2025. Its market cap has increased by 83.52% in one year.
Market Cap
333.92M
Enterprise Value
268.85M
1-Year Change
83.52%
Ranking
Category
Stock Price
$17.27
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $333.92M, an increase of 86.62%. That is a compound annual growth rate of 5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 333.92M | 85.13% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |